David L Selwood

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 16

Top Topics

Transforming Growth Factor

Cerebral Ischemia

Top Venues

Science advances

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Valeria Pingitore, Jessica Pancholi, Thomas W Hornsby, Justin Warne, Gareth Pryce, Laura J McCormick, Julia Hill, Gauri Bhosale, Jing Peng, Lydia S Newton, Greg J Towers, Simon J Coles, Ah Wing Edith Chan, Michael R Duchen, Gyorgy Szabadkai, David Baker, David L Selwood
Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration. Science advances 10 (28) (2024)
Valeria Pingitore, Jessica Pancholi, Thomas W Hornsby, Justin Warne, Gareth Pryce, Laura J McCormick, Julia Hill, Gauri Bhosale, Jing Peng, Lydia S Newton, Greg J Towers, Simon J Coles, Ah Wing Edith Chan, Michael R Duchen, Gyorgy Szabadkai, David Baker, David L Selwood
Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration. Science advances 10 (28) (2024)
Gareth Pryce, Sofia Sisay, Gavin Giovannoni, David L Selwood, David Baker
Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Charles Eldrid, Giovanni Martinotti, Constantina Fotinou, Tamas Yelland, Lefan Yu, Filipa Mota, David L Selwood, Snezana Djordjevic
VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins. Biomolecules 12 (3) (2022)
Robert J Smith, Cristina Perez-Ternero, Daniel Conole, Capucine Martin, Samuel H Myers, Adrian J Hobbs, David L Selwood
A Series of Substituted Bis-Aminotriazines Are Activators of the Natriuretic Peptide Receptor C. Journal of medicinal chemistry 65 (7) (2022)
Clare Mills, Sandra A Hemkemeyer, Zerin Alimajstorovic, Chantelle Bowers, Malihe Eskandarpour, John Greenwood, Virginia Calder, Ah Wing Edith Chan, Paul J Gane, David L Selwood, Karl Matter, Maria S Balda
Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease. Cells 11 (11) (2022)
Maddalena Rupnik, David Baker, David L Selwood
Oligodendrocytes, BK channels and the preservation of myelin. F1000Research 10 (2021)
Maddalena Rupnik, David Baker, David L Selwood
Oligodendrocytes, BK channels and remyelination. F1000Research 10 (2021)
Filipa Mota, Tamas Yelland, Jennie A Hutton, Jennifer Parker, Anastasia Patsiarika, A W Edith Chan, Andrew O'Leary, Constantina Fotinou, John F Martin, Ian C Zachary, Snezana Djordjevic, Paul Frankel, David L Selwood
Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1. Chembiochem : a European journal of chemical biology (2021)
Daniel Conole, Yi-Tai Chou, Anastasia Patsiarika, Valery Nwabo, Eleni Dimitriou, Christelle Soudy, Filipa Mota, Snezana Djordjevic, David L Selwood
Discovery of a novel fluorescent chemical probe suitable for evaluation of neuropilin-1 binding of small molecules. Drug development research 81 (4) (2020)
Aaron Gregson, Kaitlyn Thompson, Stella E Tsirka, David L Selwood
Emerging small-molecule treatments for multiple sclerosis: focus on B cells. F1000Research 8 (2019)
Robert G Keynes, Anastasia Karchevskaya, Dieter Riddall, Charmaine H Griffiths, Tomas C Bellamy, A W Edith Chan, David L Selwood, John Garthwaite
N10 -carbonyl-substituted phenothiazines inhibiting lipid peroxidation and associated nitric oxide consumption powerfully protect brain tissue against oxidative stress. Chemical biology & drug design 94 (3) (2019)
Jihee Kim, Beatrice Lana, Silvia Torelli, David Ryan, Francesco Catapano, Pierpaolo Ala, Christin Luft, Elizabeth Stevens, Evangelos Konstantinidis, Sandra Louzada, Beiyuan Fu, Amaia Paredes-Redondo, Aw Edith Chan, Fengtang Yang, Derek L Stemple, Pentao Liu, Robin Ketteler, David L Selwood, Francesco Muntoni, Yung-Yao Lin
A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan. EMBO reports 20 (11) (2019)
Setareh Tabatabaee, David Baker, David L Selwood, Benjamin J Whalley, Gary J Stephens
The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2+-Activated K+ Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing. Pharmaceuticals (Basel, Switzerland) 12 (3) (2019)
Jonathan Powell, Filipa Mota, David Steadman, Christelle Soudy, Jeremy T Miyauchi, Stuart Crosby, Ashley Jarvis, Tifelle Reisinger, Natalie Winfield, Graham Evans, Aled Finniear, Tamas Yelland, Yi-Tai Chou, A W Edith Chan, Andrew O'Leary, Lili Cheng, Dan Liu, Constantina Fotinou, Carla Milagre, John F Martin, Haiyan Jia, Paul Frankel, Snezana Djordjevic, Stella E Tsirka, Ian C Zachary, David L Selwood
Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells. Journal of medicinal chemistry 61 (9) (2018)
Justin Warne, Gareth Pryce, Julia M Hill, Xiao Shi, Felicia Lennerås, Fabiola Puentes, Maarten Kip, Laura Hilditch, Paul Walker, Michela I Simone, A W Edith Chan, Greg J Towers, Alun R Coker, Michael R Duchen, Gyorgy Szabadkai, David Baker, David L Selwood
Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis. The Journal of biological chemistry 291 (9) (2015)